Gustafsson Jan, Alimohammadi Mohammad, Ekwall Olov, Gebre-Medhin Gennet, Halldin-Stenlid Maria, Hedstrand Håkan, Landgren Eva, Nilsson Thomas, Rorsman Fredrik, Sköldberg Filip, Winqvist Ola, Kämpe Olle
Institutionen för kvinnors och barns hälsa, Akademiska barnsjukhuset, Uppsala, Sweden.
Lakartidningen. 2004 Jun 10;101(24):2096-8, 2101-3.
Autoimmune polyglandular syndrome type I (APS I) is an autosomal recessive disorder characterized by a combination of autoimmune manifestations affecting endocrine and non-endocrine organs. APS I usually presents in childhood. The three most common manifestations are chronic mucocutaneous candidiasis, hypoparathyroidism and Addison's disease. At least two of these must be present to fulfill the diagnostic criteria of this syndrome. The spectrum of other associated diseases includes gonadal insufficiency, alopecia, vitiligo and chronic active hepatitis. APS I is caused by a mutation in the AIRE-gene (autoimmune regulator) located on chromosome 21. Analysis of specific autoantibodies against intracellular enzymes, particularly enzymes in the synthesis of steroids and neurotransmittors, can be used in the diagnosis of APS I and to predict different manifestations of the disease.
I型自身免疫性多腺体综合征(APS I)是一种常染色体隐性疾病,其特征为影响内分泌和非内分泌器官的自身免疫表现的组合。APS I通常在儿童期出现。三种最常见的表现是慢性黏膜皮肤念珠菌病、甲状旁腺功能减退和艾迪生病。必须至少出现其中两种才能满足该综合征的诊断标准。其他相关疾病的范围包括性腺功能不全、脱发、白癜风和慢性活动性肝炎。APS I由位于21号染色体上的AIRE基因(自身免疫调节因子)突变引起。针对细胞内酶,特别是类固醇和神经递质合成中的酶的特异性自身抗体分析,可用于APS I的诊断和预测该疾病的不同表现。